Dowling & Yahnke LLC Abbott Laboratories Transaction History

Dowling & Yahnke LLC

$215 Million
Q3 2022

A detailed history of Dowling & Yahnke LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Dowling & Yahnke LLC holds 79,018 shares of ABT stock, worth $9.07 Million. This represents 3.56% of its overall portfolio holdings.

Number of Shares

79,018

Previous 79,838 1.03%

Holding current value

$9.07 Million

Previous $8.67 Million 11.85%

% of portfolio

3.56%

Previous 0.41%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$96.76 - $112.03 $79,343 - $91,864	-820 Reduced 1.03%	79,018 $7.65 Million
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $56,444 - $68,223	-553 Reduced 0.69%	79,838 $8.67 Million
Q1 2022 May 04, 2022	SELL	$114.02 - $139.04 $165,214 - $201,468	-1,449 Reduced 1.77%	80,391 $9.52 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $3,350 - $4,102	29 Added 0.04%	81,840 $11.5 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $22,865 - $25,295	196 Added 0.24%	81,811 $9.66 Million
Q2 2021 Jul 21, 2021	BUY	$105.79 - $124.53 $15,974 - $18,804	151 Added 0.19%	81,615 $9.46 Million
Q1 2021 Apr 29, 2021	SELL	$108.84 - $128.23 $58,229 - $68,603	-535 Reduced 0.65%	81,464 $9.76 Million
Q4 2020 Jan 28, 2021	BUY	$105.0 - $114.42 $137,025 - $149,318	1,305 Added 1.62%	81,999 $8.98 Million
Q3 2020 Oct 19, 2020	SELL	$91.64 - $111.29 $80,001 - $97,156	-873 Reduced 1.07%	80,694 $8.78 Million
Q2 2020 Jul 31, 2020	SELL	$76.57 - $98.0 $41,960 - $53,704	-548 Reduced 0.67%	81,567 $7.46 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $259,195 - $379,014	-4,126 Reduced 4.78%	82,115 $6.48 Million
Q4 2019 Jan 27, 2020	BUY	$78.51 - $87.4 $83,142 - $92,556	1,059 Added 1.24%	86,241 $7.49 Million
Q3 2019 Oct 29, 2019	BUY	$81.84 - $88.74 $16,368 - $17,748	200 Added 0.24%	85,182 $7.13 Million
Q2 2019 Jul 22, 2019	BUY	$72.88 - $85.0 $6.19 Million - $7.22 Million	84,982 New	84,982 $7.15 Million
Q4 2018 Jan 24, 2019	SELL	$65.56 - $74.27 $5.33 Million - $6.03 Million	-81,227 Closed	0 $0
Q3 2018 Oct 30, 2018	SELL	$60.81 - $73.36 $80,086 - $96,615	-1,317 Reduced 1.6%	81,227 $5.96 Million
Q2 2018 Jul 30, 2018	BUY	$57.57 - $63.54 $5,526 - $6,099	96 Added 0.12%	82,544 $5.03 Million
Q1 2018 May 01, 2018	SELL	$56.27 - $63.62 $177,363 - $200,530	-3,152 Reduced 3.68%	82,448 $4.94 Million
Q4 2017 Feb 02, 2018	BUY	$53.68 - $57.47 $43,158 - $46,205	804 Added 0.95%	85,600 $4.89 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $4.08 Million - $4.55 Million	84,796	84,796 $4.53 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.

Account

Dowling & Yahnke LLC Abbott Laboratories Transaction History